Obesity & T2D 360° Updates in the Management of Chronic Weight and Type 2 Diabetes
Free
Log In
Overview
Communicate Mounjaro value proposition and its use in day-to-day practice for people with type 2 Diabetes and Obesity.
This Activity for
- Podiatry
- Clinical Nutrition
- Nursing and Midwifery
- Resident / Fellow
- Physician
- Pharmacy
- Clinical Pharmacy
- Cardiac Perfusion
What I will learn?
- Discuss the latest guidelines and recommendations for obesity management from leading health organizations such as the American Diabetes Association (ADA) and the World Health Organization (WHO).
- Describe the appropriate patient selection criteria for new emerging weight management agents
- Examine the clinical data that supports the use of GIP/GLP-1 receptor agonists in treatment of type 2 diabetes especially in overweight patients
- Illustrate the available strategies of how to manage the side effects of new emerging therapeutic agent during the dose-escalation period
- Interpret the latest clinical trial data concerning safety and efficacy of new emerging therapeutic agents indicated for management of weight gain.
- Define the unique mechanism of action and dual benefits of GIP/GLP-1 receptor agonists in regulating blood glucose and managing weight, specifically for patients with type 2 diabetes.
- Interpret the latest updated guidelines and recommendations concerning the new emerging therapeutic agents that are indicated for regulating blood glucose and managing weight, specifically for patients with type 2 diabetes.
About Organizer
- Virtual Medical Academy
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
| Obesity & T2D 360° Updates in the Management of Chronic Weight and Type 2 Diabetes | Certificate | Free |